Stereotactic Curie-therapy of pituitary adenomas. A long-term follow-up study.
D000239:Adenoma, Acidophil / Q000532:radiotherapy* / Q000534:rehabilitation; D000238:Adenoma, Chromophobe / Q000532:radiotherapy* / Q000534:rehabilitation; D005500:Follow-Up Studies; D006048:Gold Colloid, Radioactive / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007495:Iridium / Q000627:therapeutic use; D010761:Phosphorus Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D010910:Pituitary Irradiation / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D010911:Pituitary Neoplasms / Q000532:radiotherapy*; D011868:Radioisotopes / Q000627:therapeutic use; D013238:Stereotaxic Techniques / Q000009:adverse effects / Q000401:mortality; D013997:Time Factors; D014786:Vision Disorders / Q000209:etiology; D014794:Visual Fields; D015020:Yttrium Isotopes / Q000627:therapeutic use
D006048:Gold Colloid, Radioactive; D010761:Phosphorus Radioisotopes; D011868:Radioisotopes; D015020:Yttrium Isotopes; D007495:Iridium